Doubling Down in Multiple Sclerosis: Targeting Both Innate and Adaptive Immunity

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Moderator

Gavin Giovannoni, MBBCh, PhD, FRCP, FRCPath

Professor and Chair of Neurology
Barts and the London School of Medicine and Dentistry
London, United Kingdom

Disclosures

Gavin Giovannoni, MBBCh, PhD, FRCP, FRCPath, has the following relevant financial relationships:
Consultant or advisor for: AbbVie Inc.; Aslan; Atara Biotherapeutics; Biogen; Bristol Myers Squibb-Celgene Corporation; EMD Serono, Inc.; GlaxoSmithKline; Janssen/Johnson & Johnson; Japanese Tobacco Inc.; Jazz Pharmaceuticals, Inc.; LIFNano Therapeutics; Merck & Co., Inc.; Merck KGaA; Novartis; Sanofi; Roche/Genentech
Speaker or member of speakers bureau for: Corpus
Research funding from: Biogen; Merck KgaA; EMD Serono Inc., Novartis; Sanofi; Roche/Genentech; Takeda

Faculty

Martin S. Weber, MD, PhD

Professor of Translational Neuroinflammation
Head, Clinical Multiple Sclerosis Center
Deputy Director
Department of Neurology
University of Göttingen
Göttingen, Germany

Disclosures

Martin S. Weber, MD, PhD, has no relevant financial relationships.

Editor

Leanne Fairley, BJ Hon

Medical Education Director, WebMD Global, LLC

Disclosures

Leanne Fairley, BJ Hon, has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.